
Reset all filters
01 3Lo Loestrin
02 1Lo Loestrin Fe
03 1Minastrin
04 3Minastrin24
Norethindrone Acetate, Ethinyl Estradiol
Main Therapeutic Indication : Sexual Health
Currency : USD
2017 Revenue in Millions : 459
2016 Revenue in Millions : 404
Growth (%) : 14
Ethinyl Estradiol, Norethindrone
Main Therapeutic Indication : Sexual Health
Currency : USD
2017 Revenue in Millions : 61
2016 Revenue in Millions : 327
Growth (%) : -81
Norethindrone Acetate, Ethinyl Estradiol
Main Therapeutic Indication : Sexual Health
Currency : USD
2018 Revenue in Millions : 528
2017 Revenue in Millions : 459
Growth (%) : 15%
Ethinyl Estradiol, Norethindrone
Main Therapeutic Indication : Sexual Health
Currency : USD
2018 Revenue in Millions : 10
2017 Revenue in Millions : 61
Growth (%) : -84%
Norethindrone Acetate, Ethinyl Estradiol
Main Therapeutic Indication : Contraception
Currency : USD
2016 Revenue in Millions : 404
2015 Revenue in Millions : 350
Growth (%) : 15
Ethinyl Estradiol, Norethindrone
Main Therapeutic Indication : Contraception
Currency : USD
2016 Revenue in Millions : 327
2015 Revenue in Millions : 273
Growth (%) : 20
Norethindrone acetate, Ethinyl estradiol
Main Therapeutic Indication : Sexual health
Currency : USD
2014 Revenue in Millions : 337.80%
2013 Revenue in Millions :
Growth (%) :
Norethindrone acetate, Ethinyl estradiol
Main Therapeutic Indication : Sexual health
Currency : USD
2014 Revenue in Millions : 291.20%
2013 Revenue in Millions :
Growth (%) :